Significant upregulation of PD-L2 expression on CD3+ T cells, CD3+CD56+ (NCAM) T cells, and CD8+CD25+ (IL-2RA) T cells was noted in the AD patients (Fig. 2E). The gene discussed is CD8A; the disease is Alzheimer disease.